{"id":25013,"date":"2024-07-25T08:41:58","date_gmt":"2024-07-25T06:41:58","guid":{"rendered":"https:\/\/projects.leitat.org\/home\/?p=25013"},"modified":"2025-02-05T20:25:48","modified_gmt":"2025-02-05T20:25:48","slug":"proyecto-nanovac2","status":"publish","type":"post","link":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/","title":{"rendered":"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas"},"content":{"rendered":"\r\n<p>Las alergias alimenticias son un problema de salud significativo que afecta a m\u00e1s de 17 millones de personas en Europa, con riesgos graves que incluyen reacciones potencialmente mortales. Actualmente, los tratamientos disponibles son limitados y no ofrecen una soluci\u00f3n completa para la inmunizaci\u00f3n de los pacientes.<\/p>\r\n\r\n\r\n\r\n<p>En respuesta a esta necesidad urgente, InnoUp Farma y Leitat est\u00e1n colaborando en el proyecto NANOVAC2. Su objetivo es desarrollar un tratamiento innovador y efectivo para pacientes con alergias alimenticias severas. Este tratamiento utilizar\u00e1 nanopart\u00edculas administradas por v\u00eda oral, lo que promete ser m\u00e1s accesible y f\u00e1cil de manejar en comparaci\u00f3n con las opciones actuales.<\/p>\r\n\r\n\r\n\r\n<p>El consorcio se basar\u00e1 en las patentes existentes de InnoUp Farma y en la experiencia de Leitat en cultivos celulares y ensayos precl\u00ednicos (cultivos celulares y ensayos in vivo e in vitro). Esta colaboraci\u00f3n estrat\u00e9gica acelerar\u00e1 el desarrollo de un tratamiento que podr\u00eda ofrecer una alternativa menos invasiva y m\u00e1s econ\u00f3mica para los pacientes, en lugar de depender de vacunas peri\u00f3dicas y costosas.<\/p>\r\n\r\n\r\n\r\n<p>NANOVAC2 representa un avance prometedor en la investigaci\u00f3n de tratamientos orales para alergias alimenticias, con el potencial de mejorar significativamente la calidad de vida de millones de personas afectadas en todo el mundo.<\/p>\r\n\r\n\r\n\r\n<p>Proyecto CPP2022- 009768 financiado por:<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" width=\"387\" height=\"71\" class=\"wp-image-25007\" style=\"width: 308px; height: auto;\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/Imagen1.png\" alt=\"\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/Imagen1.png 387w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/Imagen1-300x55.png 300w\" sizes=\"(max-width: 387px) 100vw, 387px\" \/><\/figure>\r\n","protected":false},"excerpt":{"rendered":"<p>Las alergias alimenticias son un problema de salud significativo que afecta a m\u00e1s de 17 millones de personas en Europa, con riesgos graves que incluyen reacciones potencialmente mortales. Actualmente, los tratamientos disponibles son limitados y no ofrecen una soluci\u00f3n completa para la inmunizaci\u00f3n de los pacientes. En respuesta a esta necesidad urgente, InnoUp Farma y [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":25016,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[13,14],"tags":[],"class_list":["post-25013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aei","category-health-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas - Leitat Technological Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas - Leitat Technological Center\" \/>\n<meta property=\"og:description\" content=\"Las alergias alimenticias son un problema de salud significativo que afecta a m\u00e1s de 17 millones de personas en Europa, con riesgos graves que incluyen reacciones potencialmente mortales. Actualmente, los tratamientos disponibles son limitados y no ofrecen una soluci\u00f3n completa para la inmunizaci\u00f3n de los pacientes. En respuesta a esta necesidad urgente, InnoUp Farma y [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/\" \/>\n<meta property=\"og:site_name\" content=\"Leitat Technological Center\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-25T06:41:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T20:25:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dissemination Manager\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dissemination Manager\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/\"},\"author\":{\"name\":\"Dissemination Manager\",\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2\"},\"headline\":\"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas\",\"datePublished\":\"2024-07-25T06:41:58+00:00\",\"dateModified\":\"2025-02-05T20:25:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/\"},\"wordCount\":229,\"publisher\":{\"@id\":\"https:\/\/leitat.org\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg\",\"articleSection\":[\"AEI\",\"Health technologies\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/\",\"url\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/\",\"name\":\"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas - Leitat Technological Center\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg\",\"datePublished\":\"2024-07-25T06:41:58+00:00\",\"dateModified\":\"2025-02-05T20:25:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"HOME\",\"item\":\"https:\/\/leitat.org\/es\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AEI\",\"item\":\"https:\/\/leitat.org\/es\/blog\/category\/aei\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leitat.org\/es\/#website\",\"url\":\"https:\/\/leitat.org\/es\/\",\"name\":\"Leitat Technological Center\",\"description\":\"Managing Technologies\",\"publisher\":{\"@id\":\"https:\/\/leitat.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leitat.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leitat.org\/es\/#organization\",\"name\":\"Leitat Technological Center\",\"url\":\"https:\/\/leitat.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"width\":226,\"height\":78,\"caption\":\"Leitat Technological Center\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2\",\"name\":\"Dissemination Manager\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"caption\":\"Dissemination Manager\"},\"sameAs\":[\"https:\/\/leitat.org\"],\"url\":\"https:\/\/leitat.org\/es\/blog\/author\/editor-wp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas - Leitat Technological Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas - Leitat Technological Center","og_description":"Las alergias alimenticias son un problema de salud significativo que afecta a m\u00e1s de 17 millones de personas en Europa, con riesgos graves que incluyen reacciones potencialmente mortales. Actualmente, los tratamientos disponibles son limitados y no ofrecen una soluci\u00f3n completa para la inmunizaci\u00f3n de los pacientes. En respuesta a esta necesidad urgente, InnoUp Farma y [&hellip;]","og_url":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/","og_site_name":"Leitat Technological Center","article_published_time":"2024-07-25T06:41:58+00:00","article_modified_time":"2025-02-05T20:25:48+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg","type":"image\/jpeg"}],"author":"Dissemination Manager","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dissemination Manager","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#article","isPartOf":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/"},"author":{"name":"Dissemination Manager","@id":"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2"},"headline":"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas","datePublished":"2024-07-25T06:41:58+00:00","dateModified":"2025-02-05T20:25:48+00:00","mainEntityOfPage":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/"},"wordCount":229,"publisher":{"@id":"https:\/\/leitat.org\/es\/#organization"},"image":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg","articleSection":["AEI","Health technologies"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/","url":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/","name":"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas - Leitat Technological Center","isPartOf":{"@id":"https:\/\/leitat.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage"},"image":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg","datePublished":"2024-07-25T06:41:58+00:00","dateModified":"2025-02-05T20:25:48+00:00","breadcrumb":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#primaryimage","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/nanovac222.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-nanovac2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"HOME","item":"https:\/\/leitat.org\/es\/home\/"},{"@type":"ListItem","position":2,"name":"AEI","item":"https:\/\/leitat.org\/es\/blog\/category\/aei\/"},{"@type":"ListItem","position":3,"name":"Proyecto NANOVAC2: Tratamiento Oral para Alergias Alimenticias Basado en Nanopart\u00edculas"}]},{"@type":"WebSite","@id":"https:\/\/leitat.org\/es\/#website","url":"https:\/\/leitat.org\/es\/","name":"Leitat Technological Center","description":"Managing Technologies","publisher":{"@id":"https:\/\/leitat.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leitat.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/leitat.org\/es\/#organization","name":"Leitat Technological Center","url":"https:\/\/leitat.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","width":226,"height":78,"caption":"Leitat Technological Center"},"image":{"@id":"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2","name":"Dissemination Manager","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","caption":"Dissemination Manager"},"sameAs":["https:\/\/leitat.org"],"url":"https:\/\/leitat.org\/es\/blog\/author\/editor-wp\/"}]}},"_links":{"self":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts\/25013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/comments?post=25013"}],"version-history":[{"count":1,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts\/25013\/revisions"}],"predecessor-version":[{"id":61637,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts\/25013\/revisions\/61637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/media\/25016"}],"wp:attachment":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/media?parent=25013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/categories?post=25013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/tags?post=25013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}